查看原文
其他

招聘细胞和基因治疗CTO/VP

医药荐客 医药荐客 2023-05-01

职位1:CGT CDO 工艺&QA VP-上海

管理PD/AD,生产,QA/QC等多个部门

职位要求:

  1. 博士,有海外留学或工作背景

  2. 5年以上细胞与基因治疗或抗体药物CMC开发和生产经验

  3. 曾参与过国内外上市药物或进入到临床阶段的药物开发

  4. 有管理10人以上团队经验


职位2:CTO of Plasmid and Virus-美国

The CTO of plasmid & virus department will provide the strategy making, production execution, project management, service capacity upgrade, technology guidance, team building and business development for the platform of plasmid & virus including CMC development for pre-IND application, GMP manufacturing for clinic trail and commercial. This position will provide strategic leadership to establish cutting-edge platforms for plasmid & virus CDMO service, and ensure the platform follow the appropriate scientific, regulatory and quality standards for gene therapy and cell therapy.

Qualifications:

PhD in biotechnology;

2. Specialized in CAR-T/TCR-T and other immune cell therapy technologies, gene editing and gene therapy technologies; forward-looking in industry development, with independent thinking and judgment ability;

3. More than 5 years of experience in gene therapy/cell therapy project development, and at least one of the development projects has entered phase 1 clinical; more than 2 years preclinical CMC development, clinical sample production or commercial production;

4. Experience in virus vector industrialization is preferred

5. Familiar with the CMC development process of biological products, global application regulations and drug production management standards;

6. More than 5 years of team management experience;

7. Experience in GMP facility management is preferred, and experience in pharmaceutical company management;

8. Have experience in GMP facility design, construction and validation. The GMP workshop meets the requirements of NMPA, FDA and EMA regulations.

欢迎自荐推荐和转发分享,电话/微信:13564288425



生物医药职位汇总-202301

小核酸公司需要化学/生物/递送Director/O级别人才加盟

抗体CDMO公司招聘CTO-中/美

宁波急聘药化/DMPK/制剂硕士(短期可以在家办公)

武汉药企招聘药化/药效/病毒机理总监或更高级别

江苏药企招聘药学副总裁(制剂方向)

招聘美国BD AD/SD level(WFH,out licensing)

招聘质粒平台研发总监和病毒工艺开发高级科学家

综述靶向蛋白降解(TPD):PROTAC、LYTAC、分子胶、光控PROTAC...

2022年全球医药M&A总结

ADC的迭代史

盘点:中国的62家合成生物初创企业

外泌体行业分析报告

重磅!mRNA行业全景图:火种已燃,大势已至,聚力向前,技术为王

一份研报读懂:类器官行业

溶瘤病毒行业深度研究报告

"置身Science内" - From PhD to BD(想转BD的看过来)

您可能也对以下帖子感兴趣

文章有问题?点此查看未经处理的缓存